BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 22879423)

  • 1. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
    Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between maternal carotenoid status and newborn infant macular pigment optical density and carotenoid status.
    Henriksen BS; Chan G; Hoffman RO; Sharifzadeh M; Ermakov IV; Gellermann W; Bernstein PS
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5568-78. PubMed ID: 23838770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
    Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
    Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
    Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
    Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
    Stringham JM; Stringham NT
    Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
    Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blue-light reflectance imaging of macular pigment in infants and children.
    Bernstein PS; Sharifzadeh M; Liu A; Ermakov I; Nelson K; Sheng X; Panish C; Carlstrom B; Hoffman RO; Gellermann W
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4034-40. PubMed ID: 23652486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
    Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
    Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial.
    Addo EK; Gorusupudi A; Allman S; Bernstein PS
    Trials; 2021 Apr; 22(1):300. PubMed ID: 33888136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative.
    LaRowe TL; Mares JA; Snodderly DM; Klein ML; Wooten BR; Chappell R;
    Ophthalmology; 2008 May; 115(5):876-883.e1. PubMed ID: 17868874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
    Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations Between Macular, Skin, and Serum Carotenoids.
    Conrady CD; Bell JP; Besch BM; Gorusupudi A; Farnsworth K; Ermakov I; Sharifzadeh M; Ermakova M; Gellermann W; Bernstein PS
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3616-3627. PubMed ID: 28728169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.